Israel's Aion Labs Establishes TenAces to Develop New Molecular Glue Therapies
AION Labs, an Israeli organization that is the first-of-its-kind venture studio “spearheading” the adoption of AI technologies and computational science to solve therapeutic challenges, formed the new venture TenAces Biosciences. TenAces is a startup developing what it describes as a novel approach to discovering new molecular glue therapies, leveraging machine learning to enhance the development […]
Source: jewishbusinessnews.com